Yuluğ, BurakHano?lu, LütfüOzansoy, MehmetIşık, DoğanKılıç, ÜlkanKılıç, ErtuğrulSchabitz, Wolf Rüdiger10.07.20192019-07-1010.07.20192019-07-102018Yuluğ, B., Hano?lu, L., Ozansoy, M., Işık, D., Kılıç, Ü., Kılıç, E. ... Schabitz, W. (2018). Therapeutic role of rifampicin in Alzheimer's disease. Psychiatry and Clinical Neurosciences, 72(3), 152-159. https://dx.doi.org/10.1111/pcn.126371323-13161440-1819https://dx.doi.org/10.1111/pcn.12637https://hdl.handle.net/20.500.12511/2094WOS: 000426795500003PubMed ID: 29315976Rifampicin exerts significant brain protective functions in multiple experimental models. Here we summarize the underlying mechanisms of the neuroprotective and pro-cognitive effects of rifampicin that are mediated by its anti-inflammatory, anti-tau, anti-amyloid, and cholinergic effects. Beyond suggesting that rifampicin shows strong brain protective effects in preclinical models of Alzheimer's disease, we also provide substantial clinical evidence for the neuroprotective and procognitive effects of rifampicin. Future neuroimaging studies combined with clinical assessment scores are the following steps to be taken in this field of research.eninfo:eu-repo/semantics/openAccessAlzheimer's DiseaseAmyloid Beta ClearanceNeuroprotectionOligomeric Amyloid HypothesisRifampicinReview Article72315215910.1111/pcn.12637Q1Q1